Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001829126-25-001997
Filing Date
2025-03-24
Accepted
2025-03-24 06:01:20
Documents
2
Period of Report
2025-03-24

Document Format Files

Seq Description Document Type Size
1 PRE 14C cyclacel_pre14c.htm PRE 14C 119953
2 GRAPHIC img_001.jpg GRAPHIC 19400
  Complete submission text file 0001829126-25-001997.txt   147981
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 000-50626 | Film No.: 25762118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)